CuraScientific Corp. CSTF
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 952.82% | 426.73% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 952.82% | 426.73% | -- | -- | -- |
| Cost of Revenue | 90.93% | 50.53% | -- | -- | -- |
| Gross Profit | -36.21% | -13.11% | -- | -- | -- |
| SG&A Expenses | 21.11% | 49.41% | -- | -- | -- |
| Depreciation & Amortization | 18.00% | 26.67% | -- | -- | -- |
| Other Operating Expenses | 0.00% | -50.00% | -- | -- | -- |
| Total Operating Expenses | 58.30% | 49.67% | -- | -- | -- |
| Operating Income | -32.31% | -33.64% | -- | -- | -- |
| Income Before Tax | 835.48% | 720.35% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 835.48% | 720.35% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 835.48% | 720.35% | -- | -- | -- |
| EBIT | -32.31% | -33.64% | -- | -- | -- |
| EBITDA | -3.60% | -39.27% | -- | -- | -- |
| EPS Basic | 102.64% | 101.62% | -- | -- | -- |
| Normalized Basic EPS | 109.87% | 99.92% | -- | -- | -- |
| EPS Diluted | 100.06% | 100.47% | -- | -- | -- |
| Normalized Diluted EPS | 106.25% | 98.20% | -- | -- | -- |
| Average Basic Shares Outstanding | 6,739.30% | 1,763.38% | -- | -- | -- |
| Average Diluted Shares Outstanding | 7,024.01% | 2,303.38% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |